The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies
S Elad, N Yarom, Y Zadik… - CA: a cancer journal …, 2022 - Wiley Online Library
Oral mucositis (OM) is a common, highly symptomatic complication of cancer therapy that
affects patients' function, quality of life, and ability to tolerate treatment. In certain patients …
affects patients' function, quality of life, and ability to tolerate treatment. In certain patients …
Radiation-induced oral mucositis
OM Maria, N Eliopoulos, T Muanza - Frontiers in oncology, 2017 - frontiersin.org
Radiation-induced oral mucositis (RIOM) is a major dose-limiting toxicity in head and neck
cancer patients. It is a normal tissue injury caused by radiation/radiotherapy (RT), which has …
cancer patients. It is a normal tissue injury caused by radiation/radiotherapy (RT), which has …
Current perspectives on nasopharyngeal carcinoma
Abstract Of the~ 129,079 new cases of nasopharyngeal carcinoma (NPC) and 72,987
associated deaths estimated for 2018, the majority will be geographically localized to South …
associated deaths estimated for 2018, the majority will be geographically localized to South …
Mucositis: pathobiology and management
Oral mucositis is a common complication of cancer treatment that may negatively impact the
patient's cancer treatment outcome. Despite its frequency and consequences, the lack of …
patient's cancer treatment outcome. Despite its frequency and consequences, the lack of …
Oral mucositis and microbial colonization in oral cancer patients undergoing radiotherapy and chemotherapy: A prospective analysis in a tertiary care dental hospital
N Subramaniam… - Journal of investigative and …, 2019 - Wiley Online Library
Aim The ulcerative phase of oral mucositis following radiotherapy/chemotherapy for oral
cancer colonizes bacteria, fungi and viruses. The role of a microbiota, specifically bacterial …
cancer colonizes bacteria, fungi and viruses. The role of a microbiota, specifically bacterial …
[HTML][HTML] Review on the effect of chemotherapy on the intestinal barrier: Epithelial permeability, mucus and bacterial translocation
D Dahlgren, H Lennernäs - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Chemotherapy kills fast-growing cells including gut stem cells. This affects all components of
the physical and functional intestinal barrier, ie, the mucus layer, epithelium, and immune …
the physical and functional intestinal barrier, ie, the mucus layer, epithelium, and immune …
Oncological-therapy related oral mucositis as an interdisciplinary problem—literature review
A Kusiak, BA Jereczek-Fossa, D Cichońska… - International journal of …, 2020 - mdpi.com
Oral mucositis is a toxic side effect of non-surgical cancer treatments: chemotherapy and
radiotherapy, which strongly impair quality of life and can not only cause strong pain, but …
radiotherapy, which strongly impair quality of life and can not only cause strong pain, but …
Natural products for the prevention and treatment of oral mucositis—a review
AS Ferreira, C Macedo, AM Silva… - International Journal of …, 2022 - mdpi.com
Cancer, a major world public health problem, is associated with chemotherapy treatments
whose administration leads to secondary concerns, such as oral mucositis (OM). The OM …
whose administration leads to secondary concerns, such as oral mucositis (OM). The OM …
Emerging evidence on the pathobiology of mucositis
Background Considerable progress has been made in our understanding of the biological
basis for cancer therapy-induced mucosal barrier injury (mucositis). The last formal review of …
basis for cancer therapy-induced mucosal barrier injury (mucositis). The last formal review of …
Oral mucositis due to high-dose chemotherapy and/or head and neck radiation therapy
RV Lalla, MT Brennan, SM Gordon, ST Sonis… - JNCI …, 2019 - academic.oup.com
Oral mucositis is a common side-effect associated with conventional cancer therapy and has
also recently been reported in association with newly emerging cancer therapies. It is …
also recently been reported in association with newly emerging cancer therapies. It is …